Double cord blood transplantation in patients with high risk bone marrow failure syndromes


Professor G. Socié, Service d’Hématologie-Greffe de Moelle, Hôpital Saint Louis, APHP, Paris University 7, 1 avenue Claude Vellefaux, 75010 Paris, France. E-mail:


Patients with bone marrow failure syndromes (BMFS) who reject a first allogeneic transplant or fail immunosuppressive therapy (IST) have an especially grim prognosis. We report 14 patients (eight adults, six children) transplanted with double cord blood transplantation (dUCBT) for BMFS. Neutrophil recovery was observed in eight patients, with full donor chimerism of one unit, and acute GVHD in 10. With a median follow-up of 23 months, the estimated 2 years overall survival was 80 ± 17% and 33 ± 16% for patients with acquired and inherited BMFS, respectively. Transplantation of two partially HLA-matched UCB thus enables salvage treatment of high-risk patients with BMFS.